Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Other Non Operating Income (2018 - 2024)

Lipocine (LPCN) has disclosed Other Non Operating Income for 7 consecutive years, with $3586.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non Operating Income fell 70.78% year-over-year to $3586.0, compared with a TTM value of $17165.0 through Dec 2024, down 91.93%, and an annual FY2024 reading of $17166.0, down 91.93% over the prior year.
  • Other Non Operating Income was $3586.0 for Q4 2024 at Lipocine, down from $138081.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $583445.0 in Q2 2022 and bottomed at -$3.8 million in Q2 2021.
  • Average Other Non Operating Income over 5 years is -$325360.8, with a median of $7930.0 recorded in 2023.
  • The sharpest move saw Other Non Operating Income crashed 2197.4% in 2020, then surged 676.64% in 2021.
  • Year by year, Other Non Operating Income stood at $57642.0 in 2020, then plummeted by 425.29% to -$187502.0 in 2021, then plummeted by 147.51% to -$464079.0 in 2022, then surged by 102.64% to $12274.0 in 2023, then tumbled by 70.78% to $3586.0 in 2024.
  • Business Quant data shows Other Non Operating Income for LPCN at $3586.0 in Q4 2024, $138081.0 in Q3 2024, and -$84430.0 in Q2 2024.